Opioid Use Disorder Market Size, Trends, Analysis, and Outlook By Drug (Buprenorphine, Methadone, Naltrexone), By Route of Administration (Oral, Parenteral), By Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies & Stores), by Region, Country, Segment, and Companies, 2024-2030
The global Opioid Use Disorder market size is poised to register 10.42% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Opioid Use Disorder market across By Drug (Buprenorphine, Methadone, Naltrexone), By Route of Administration (Oral, Parenteral), By Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies & Stores).
The Opioid Use Disorder (OUD) market is experiencing profound changes driven by the opioid epidemic, the increasing recognition of addiction as a chronic brain disease, and the growing demand for evidence-based treatments and recovery support services. Opioid use disorder refers to a problematic pattern of opioid use characterized by compulsive drug seeking, tolerance, physical dependence, and withdrawal symptoms, leading to significant impairment in social, occupational, and psychological functioning. Key factors influencing the OUD market include the rising awareness about the prevalence and impact of opioid addiction, the expanding opioid treatment infrastructure and capacity, and the implementation of harm reduction strategies and public health interventions to address the opioid crisis. Additionally, the growing availability of pharmacological treatments for OUD, including opioid agonist therapies (e.g., methadone, buprenorphine) and opioid antagonist therapies (e.g., naltrexone), is driving changes in treatment paradigms and patient care models. Moreover, the integration of medication-assisted treatment (MAT) with counseling, behavioral therapy, and peer support services, the expansion of telemedicine and digital health platforms for OUD management, and the development of novel pharmacotherapies and digital therapeutics for addiction recovery are shaping the future of the OUD market. Furthermore, the increasing focus on health equity and access to care, the reduction of stigma associated with addiction, and the collaboration between healthcare providers, policymakers, and community organizations are essential for addressing the complex needs of individuals with OUD and improving treatment outcomes. With the evolving regulatory landscape and the growing emphasis on evidence-based practices and patient-centered care, the OUD market is undergoing transformative changes to support recovery, reduce overdose deaths, and promote long-term wellness and recovery for individuals affected by opioid addiction.
Opioid Use Disorder Market Drivers, Trends, Opportunities, and Growth Opportunities
This comprehensive study discusses the latest trends and the most pressing challenges for industry players and investors. The Opioid Use Disorder market research analyses the global market trends, key drivers, challenges, and opportunities in the industry. In addition, the latest Future of Opioid Use Disorder survey report provides the market size outlook across types, applications, and other segments across the world and regions. It provides data-driven insights and actionable recommendations for companies in the Opioid Use Disorder industry.
Key market trends defining the global Opioid Use Disorder demand in 2024 and Beyond
The industry continues to remain an attractive hub for opportunities for both domestic and global vendors. As the market evolves, factors such as emerging market dynamics, demand from end-user sectors, a growing patient base, changes in consumption patterns, and widening distribution channels continue to play a major role.
Opioid Use Disorder Market Segmentation- Industry Share, Market Size, and Outlook to 2030
The Opioid Use Disorder industry comprises a wide range of segments and sub-segments. The rising demand for these product types and applications is supporting companies to increase their investment levels across niche segments. Accordingly, leading companies plan to generate a large share of their future revenue growth from expansion into these niche segments. The report presents the market size outlook across segments to support Opioid Use Disorder companies scaling up production in these sub-segments with a focus on expanding into emerging countries.
Key strategies adopted by companies within the Opioid Use Disorder industry
Leading Opioid Use Disorder companies are boosting investments to capitalize on untapped potential and future possibilities across niche market segments and surging demand conditions in key regions. Further, companies are leveraging advanced technologies to unlock opportunities and achieve operational excellence. The report provides key strategies opted for by the top 10 Opioid Use Disorder companies.
Opioid Use Disorder Market Study- Strategic Analysis Review
The Opioid Use Disorder market research report dives deep into the qualitative factors shaping the market, empowering you to make informed decisions-
The Opioid Use Disorder industry report provides a detailed analysis and outlook of revenue generated by companies from 2018 to 2023. Further, with actual data for 2023, the report forecasts the market size outlook from 2024 to 2030 in three case scenarios- low case, reference case, and high case scenarios.
Opioid Use Disorder Country Analysis and Revenue Outlook to 2030
The report analyses 22 countries worldwide including the key driving forces and market size outlook from 2021 to 2030. In addition, region analysis across Asia Pacific, Europe, the Middle East, Africa, North America, and South America is included in the study. For each of the six regions, the market size outlook by segments is forecast for 2030.
North America Opioid Use Disorder Market Size Outlook- Companies plan for focused investments in a changing environment
The US continues to remain the market leader in North America, driven by a large consumer base, the presence of well-established providers, and a strong end-user industry demand. Leading companies focus on new product launches in the changing environment. The US economy is expected to grow in 2024 (around 2.2% growth in 2024), potentially driving demand for various Opioid Use Disorder market segments. Similarly, Strong end-user demand is encouraging Canadian Opioid Use Disorder companies to invest in niche segments. Further, as Mexico continues to strengthen its trade relations and invest in technological advancements, the Mexico Opioid Use Disorder market is expected to experience significant expansion, offering lucrative opportunities for both domestic and international stakeholders.
Europe Opioid Use Disorder Market Size Outlook-Companies investing in assessing consumers, categories, competitors, and capabilities
The German industry remains the major market for companies in the European Opioid Use Disorder industry with consumers in Germany, France, the UK, Spain, Italy, and others anticipated to register a steady demand throughout the forecast period, driving the overall market prospects. In addition, the proactive approach of businesses in identifying and leveraging new growth prospects positions the European Opioid Use Disorder market for an upward trajectory, fostering both domestic and international interest. Leading brands operating in the industry are emphasizing effective marketing strategies, innovative product offerings, and a keen understanding of consumer preferences.
Asia Pacific Opioid Use Disorder Market Size Outlook- an attractive hub for opportunities for both local and global companies
The increasing prevalence of indications, robust healthcare expenditure, and increasing investments in healthcare infrastructure drive the demand for Opioid Use Disorder in Asia Pacific. In particular, China, India, and South East Asian Opioid Use Disorder markets present a compelling outlook for 2030, acting as a magnet for both domestic and multinational manufacturers seeking growth opportunities. Similarly, with a burgeoning population and a rising middle class, India offers a vast consumer market. Japanese and Korean companies are quickly aligning their strategies to navigate changes, explore new markets, and enhance their competitive edge. Our report utilizes in-depth interviews with industry experts and comprehensive data analysis to provide a comprehensive outlook of 6 major markets in the region.
Latin America Opioid Use Disorder Market Size Outlook- Continued urbanization and rising income levels
Rising income levels contribute to greater purchasing power among consumers, spurring consumption and creating opportunities for market expansion. Continued urbanization and rising income levels are expected to sustainably drive consumption growth in the medium to long term.
Middle East and Africa Opioid Use Disorder Market Size Outlook- continues its upward trajectory across segments
Robust demand from Middle Eastern countries including Saudi Arabia, the UAE, Qatar, Kuwait, and other GCC countries supports the overall Middle East Opioid Use Disorder market potential. Fueled by increasing healthcare expenditure of individuals, growing population, and high prevalence across a few markets drives the demand for Opioid Use Disorder.
Opioid Use Disorder Market Company Profiles
The global Opioid Use Disorder market is characterized by intense competitive conditions with leading companies opting for aggressive marketing to gain market shares. The report presents business descriptions, SWOT analysis, growth strategies, and financial profiles. Leading companies included in the study are Alkermes, Camurus AB, Collegium Pharmaceutical, Hikma Pharmaceuticals PLC, Indivior PLC, MediciNova Inc, Omeros Corp, Orexo AB, Teva Pharmaceutical Industries Ltd, Titan Pharmaceuticals Inc
Recent Opioid Use Disorder Market Developments
The global Opioid Use Disorder market study presents recent market news and developments including new product launches, mergers, acquisitions, expansions, product approvals, and other updates in the industry.
Opioid Use Disorder Market Report Scope
Parameters: Revenue, Volume Price
Study Period: 2023 (Base Year); 2018- 2023 (Historic Period); 2024- 2030 (Forecast Period)
Currency: USD; (Upon request, can be provided in Euro, JPY, GBP, and other Local Currency)
Qualitative Analysis
By Drug
Buprenorphine
-Bunavail
-Sublocade
-Suboxone
-Zubsolv
-Others
Methadone
Naltrexone
By Route of Administration
Oral
Parenteral
By Distribution Channel
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies & Stores
Geographical Segmentation:
Alkermes
Camurus AB
Collegium Pharmaceutical
Hikma Pharmaceuticals PLC
Indivior PLC
MediciNova Inc
Omeros Corp
Orexo AB
Teva Pharmaceutical Industries Ltd
Titan Pharmaceuticals Inc
Formats Available: Excel, PDF, and PPT
The Opioid Use Disorder (OUD) market is experiencing profound changes driven by the opioid epidemic, the increasing recognition of addiction as a chronic brain disease, and the growing demand for evidence-based treatments and recovery support services. Opioid use disorder refers to a problematic pattern of opioid use characterized by compulsive drug seeking, tolerance, physical dependence, and withdrawal symptoms, leading to significant impairment in social, occupational, and psychological functioning. Key factors influencing the OUD market include the rising awareness about the prevalence and impact of opioid addiction, the expanding opioid treatment infrastructure and capacity, and the implementation of harm reduction strategies and public health interventions to address the opioid crisis. Additionally, the growing availability of pharmacological treatments for OUD, including opioid agonist therapies (e.g., methadone, buprenorphine) and opioid antagonist therapies (e.g., naltrexone), is driving changes in treatment paradigms and patient care models. Moreover, the integration of medication-assisted treatment (MAT) with counseling, behavioral therapy, and peer support services, the expansion of telemedicine and digital health platforms for OUD management, and the development of novel pharmacotherapies and digital therapeutics for addiction recovery are shaping the future of the OUD market. Furthermore, the increasing focus on health equity and access to care, the reduction of stigma associated with addiction, and the collaboration between healthcare providers, policymakers, and community organizations are essential for addressing the complex needs of individuals with OUD and improving treatment outcomes. With the evolving regulatory landscape and the growing emphasis on evidence-based practices and patient-centered care, the OUD market is undergoing transformative changes to support recovery, reduce overdose deaths, and promote long-term wellness and recovery for individuals affected by opioid addiction.
Opioid Use Disorder Market Drivers, Trends, Opportunities, and Growth Opportunities
This comprehensive study discusses the latest trends and the most pressing challenges for industry players and investors. The Opioid Use Disorder market research analyses the global market trends, key drivers, challenges, and opportunities in the industry. In addition, the latest Future of Opioid Use Disorder survey report provides the market size outlook across types, applications, and other segments across the world and regions. It provides data-driven insights and actionable recommendations for companies in the Opioid Use Disorder industry.
Key market trends defining the global Opioid Use Disorder demand in 2024 and Beyond
The industry continues to remain an attractive hub for opportunities for both domestic and global vendors. As the market evolves, factors such as emerging market dynamics, demand from end-user sectors, a growing patient base, changes in consumption patterns, and widening distribution channels continue to play a major role.
Opioid Use Disorder Market Segmentation- Industry Share, Market Size, and Outlook to 2030
The Opioid Use Disorder industry comprises a wide range of segments and sub-segments. The rising demand for these product types and applications is supporting companies to increase their investment levels across niche segments. Accordingly, leading companies plan to generate a large share of their future revenue growth from expansion into these niche segments. The report presents the market size outlook across segments to support Opioid Use Disorder companies scaling up production in these sub-segments with a focus on expanding into emerging countries.
Key strategies adopted by companies within the Opioid Use Disorder industry
Leading Opioid Use Disorder companies are boosting investments to capitalize on untapped potential and future possibilities across niche market segments and surging demand conditions in key regions. Further, companies are leveraging advanced technologies to unlock opportunities and achieve operational excellence. The report provides key strategies opted for by the top 10 Opioid Use Disorder companies.
Opioid Use Disorder Market Study- Strategic Analysis Review
The Opioid Use Disorder market research report dives deep into the qualitative factors shaping the market, empowering you to make informed decisions-
- Industry Dynamics: Porter's Five Forces analysis to understand bargaining power, competitive rivalry, and threats that impact long-term strategy formulation.
- Strategic Insights: Provides valuable perspectives on key players and their approaches based on comprehensive strategy analysis.
- Internal Strengths and Weaknesses: Develop targeted strategies to leverage strengths, address weaknesses, and capitalize on market opportunities.
- Future Possibilities: Prepare for diverse outcomes with in-depth scenario analysis. Explore potential market disruptions, technology advancements, and economic changes.
The Opioid Use Disorder industry report provides a detailed analysis and outlook of revenue generated by companies from 2018 to 2023. Further, with actual data for 2023, the report forecasts the market size outlook from 2024 to 2030 in three case scenarios- low case, reference case, and high case scenarios.
Opioid Use Disorder Country Analysis and Revenue Outlook to 2030
The report analyses 22 countries worldwide including the key driving forces and market size outlook from 2021 to 2030. In addition, region analysis across Asia Pacific, Europe, the Middle East, Africa, North America, and South America is included in the study. For each of the six regions, the market size outlook by segments is forecast for 2030.
North America Opioid Use Disorder Market Size Outlook- Companies plan for focused investments in a changing environment
The US continues to remain the market leader in North America, driven by a large consumer base, the presence of well-established providers, and a strong end-user industry demand. Leading companies focus on new product launches in the changing environment. The US economy is expected to grow in 2024 (around 2.2% growth in 2024), potentially driving demand for various Opioid Use Disorder market segments. Similarly, Strong end-user demand is encouraging Canadian Opioid Use Disorder companies to invest in niche segments. Further, as Mexico continues to strengthen its trade relations and invest in technological advancements, the Mexico Opioid Use Disorder market is expected to experience significant expansion, offering lucrative opportunities for both domestic and international stakeholders.
Europe Opioid Use Disorder Market Size Outlook-Companies investing in assessing consumers, categories, competitors, and capabilities
The German industry remains the major market for companies in the European Opioid Use Disorder industry with consumers in Germany, France, the UK, Spain, Italy, and others anticipated to register a steady demand throughout the forecast period, driving the overall market prospects. In addition, the proactive approach of businesses in identifying and leveraging new growth prospects positions the European Opioid Use Disorder market for an upward trajectory, fostering both domestic and international interest. Leading brands operating in the industry are emphasizing effective marketing strategies, innovative product offerings, and a keen understanding of consumer preferences.
Asia Pacific Opioid Use Disorder Market Size Outlook- an attractive hub for opportunities for both local and global companies
The increasing prevalence of indications, robust healthcare expenditure, and increasing investments in healthcare infrastructure drive the demand for Opioid Use Disorder in Asia Pacific. In particular, China, India, and South East Asian Opioid Use Disorder markets present a compelling outlook for 2030, acting as a magnet for both domestic and multinational manufacturers seeking growth opportunities. Similarly, with a burgeoning population and a rising middle class, India offers a vast consumer market. Japanese and Korean companies are quickly aligning their strategies to navigate changes, explore new markets, and enhance their competitive edge. Our report utilizes in-depth interviews with industry experts and comprehensive data analysis to provide a comprehensive outlook of 6 major markets in the region.
Latin America Opioid Use Disorder Market Size Outlook- Continued urbanization and rising income levels
Rising income levels contribute to greater purchasing power among consumers, spurring consumption and creating opportunities for market expansion. Continued urbanization and rising income levels are expected to sustainably drive consumption growth in the medium to long term.
Middle East and Africa Opioid Use Disorder Market Size Outlook- continues its upward trajectory across segments
Robust demand from Middle Eastern countries including Saudi Arabia, the UAE, Qatar, Kuwait, and other GCC countries supports the overall Middle East Opioid Use Disorder market potential. Fueled by increasing healthcare expenditure of individuals, growing population, and high prevalence across a few markets drives the demand for Opioid Use Disorder.
Opioid Use Disorder Market Company Profiles
The global Opioid Use Disorder market is characterized by intense competitive conditions with leading companies opting for aggressive marketing to gain market shares. The report presents business descriptions, SWOT analysis, growth strategies, and financial profiles. Leading companies included in the study are Alkermes, Camurus AB, Collegium Pharmaceutical, Hikma Pharmaceuticals PLC, Indivior PLC, MediciNova Inc, Omeros Corp, Orexo AB, Teva Pharmaceutical Industries Ltd, Titan Pharmaceuticals Inc
Recent Opioid Use Disorder Market Developments
The global Opioid Use Disorder market study presents recent market news and developments including new product launches, mergers, acquisitions, expansions, product approvals, and other updates in the industry.
Opioid Use Disorder Market Report Scope
Parameters: Revenue, Volume Price
Study Period: 2023 (Base Year); 2018- 2023 (Historic Period); 2024- 2030 (Forecast Period)
Currency: USD; (Upon request, can be provided in Euro, JPY, GBP, and other Local Currency)
Qualitative Analysis
- Pricing Analysis
- Value Chain Analysis
- SWOT Profile
- Market Dynamics- Trends, Drivers, Challenges
- Porter’s Five Forces Analysis
- Macroeconomic Impact Analysis
- Case Scenarios- Low, Base, High
By Drug
Buprenorphine
-Bunavail
-Sublocade
-Suboxone
-Zubsolv
-Others
Methadone
Naltrexone
By Route of Administration
Oral
Parenteral
By Distribution Channel
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies & Stores
Geographical Segmentation:
- North America (3 markets)
- Europe (6 markets)
- Asia Pacific (6 markets)
- Latin America (3 markets)
- Middle East Africa (5 markets)
Alkermes
Camurus AB
Collegium Pharmaceutical
Hikma Pharmaceuticals PLC
Indivior PLC
MediciNova Inc
Omeros Corp
Orexo AB
Teva Pharmaceutical Industries Ltd
Titan Pharmaceuticals Inc
Formats Available: Excel, PDF, and PPT
1. EXECUTIVE SUMMARY
1.1 Opioid Use Disorder Market Overview and Key Findings, 2024
1.2 Opioid Use Disorder Market Size and Growth Outlook, 2021- 2030
1.3 Opioid Use Disorder Market Growth Opportunities to 2030
1.4 Key Opioid Use Disorder Market Trends and Challenges
1.4.1 Opioid Use Disorder Market Drivers and Trends
1.4.2 Opioid Use Disorder Market Challenges
1.5 Competitive Landscape and Key Players
1.6 Competitive Analysis- Growth Strategies Adopted by Leading Opioid Use Disorder Companies
2. OPIOID USE DISORDER MARKET SIZE OUTLOOK TO 2030
2.1 Opioid Use Disorder Market Size Outlook, USD Million, 2021- 2030
2.2 Opioid Use Disorder Incremental Market Growth Outlook, %, 2021- 2030
2.3 Segment Snapshot, 2024
3. OPIOID USE DISORDER MARKET- STRATEGIC ANALYSIS REVIEW
3.1 Porter's Five Forces Analysis
* Threat of New Entrants
* Threat of Substitutes
* Intensity of Competitive Rivalry
* Bargaining Power of Buyers
* Bargaining Power of Suppliers
3.2 Value Chain Analysis
3.3 SWOT Analysis
4. OPIOID USE DISORDER MARKET SEGMENTATION ANALYSIS AND OUTLOOK
4.1 Market Segmentation and Scope
4.2 Market Breakdown by Type, Application, and Other Segments, 2021-2030
By Drug
Buprenorphine
-Bunavail
-Sublocade
-Suboxone
-Zubsolv
-Others
Methadone
Naltrexone
By Route of Administration
Oral
Parenteral
By Distribution Channel
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies & Stores
4.3 Growth Prospects and Niche Opportunities, 2023- 2030
4.4 Regional comparison of Market Growth, CAGR, 2023-2030
5. REGION-WISE MARKET OUTLOOK TO 2030
5.1 Key Findings for Asia Pacific Opioid Use Disorder Market, 2025
5.2 Asia Pacific Opioid Use Disorder Market Size Outlook by Type, 2021- 2030
5.3 Asia Pacific Opioid Use Disorder Market Size Outlook by Application, 2021- 2030
5.4 Key Findings for Europe Opioid Use Disorder Market, 2025
5.5 Europe Opioid Use Disorder Market Size Outlook by Type, 2021- 2030
5.6 Europe Opioid Use Disorder Market Size Outlook by Application, 2021- 2030
5.7 Key Findings for North America Opioid Use Disorder Market, 2025
5.8 North America Opioid Use Disorder Market Size Outlook by Type, 2021- 2030
5.9 North America Opioid Use Disorder Market Size Outlook by Application, 2021- 2030
5.10 Key Findings for South America Opioid Use Disorder Market, 2025
5.11 South America Pacific Opioid Use Disorder Market Size Outlook by Type, 2021- 2030
5.12 South America Opioid Use Disorder Market Size Outlook by Application, 2021- 2030
5.13 Key Findings for Middle East and Africa Opioid Use Disorder Market, 2025
5.14 Middle East Africa Opioid Use Disorder Market Size Outlook by Type, 2021- 2030
5.15 Middle East Africa Opioid Use Disorder Market Size Outlook by Application, 2021- 2030
6. COUNTRY-WISE MARKET SIZE OUTLOOK TO 2030
6.1 US Opioid Use Disorder Market Size Outlook and Revenue Growth Forecasts
6.2 US Opioid Use Disorder Industry Drivers and Opportunities
6.3 Canada Market Size Outlook and Revenue Growth Forecasts
6.4 Canada Opioid Use Disorder Industry Drivers and Opportunities
6.6 Mexico Market Size Outlook and Revenue Growth Forecasts
6.6 Mexico Opioid Use Disorder Industry Drivers and Opportunities
6.7 Germany Market Size Outlook and Revenue Growth Forecasts
6.8 Germany Opioid Use Disorder Industry Drivers and Opportunities
6.9 France Market Size Outlook and Revenue Growth Forecasts
6.10 France Opioid Use Disorder Industry Drivers and Opportunities
6.11 UK Market Size Outlook and Revenue Growth Forecasts
6.12 UK Opioid Use Disorder Industry Drivers and Opportunities
6.13 Spain Market Size Outlook and Revenue Growth Forecasts
6.14 Spain Opioid Use Disorder Industry Drivers and Opportunities
6.16 Italy Market Size Outlook and Revenue Growth Forecasts
6.16 Italy Opioid Use Disorder Industry Drivers and Opportunities
6.17 Rest of Europe Market Size Outlook and Revenue Growth Forecasts
6.18 Rest of Europe Opioid Use Disorder Industry Drivers and Opportunities
6.19 China Market Size Outlook and Revenue Growth Forecasts
6.20 China Opioid Use Disorder Industry Drivers and Opportunities
6.21 India Market Size Outlook and Revenue Growth Forecasts
6.22 India Opioid Use Disorder Industry Drivers and Opportunities
6.23 Japan Market Size Outlook and Revenue Growth Forecasts
6.24 Japan Opioid Use Disorder Industry Drivers and Opportunities
6.26 South Korea Market Size Outlook and Revenue Growth Forecasts
6.26 South Korea Opioid Use Disorder Industry Drivers and Opportunities
6.27 Australia Market Size Outlook and Revenue Growth Forecasts
6.28 Australia Opioid Use Disorder Industry Drivers and Opportunities
6.29 South East Asia Market Size Outlook and Revenue Growth Forecasts
6.30 South East Asia Opioid Use Disorder Industry Drivers and Opportunities
6.31 Rest of Asia Pacific Market Size Outlook and Revenue Growth Forecasts
6.32 Rest of Asia Pacific Opioid Use Disorder Industry Drivers and Opportunities
6.33 Brazil Market Size Outlook and Revenue Growth Forecasts
6.34 Brazil Opioid Use Disorder Industry Drivers and Opportunities
6.36 Argentina Market Size Outlook and Revenue Growth Forecasts
6.36 Argentina Opioid Use Disorder Industry Drivers and Opportunities
6.37 Rest of South America Market Size Outlook and Revenue Growth Forecasts
6.38 Rest of South America Opioid Use Disorder Industry Drivers and Opportunities
6.39 Middle East Market Size Outlook and Revenue Growth Forecasts
6.40 Middle East Opioid Use Disorder Industry Drivers and Opportunities
6.41 Africa Market Size Outlook and Revenue Growth Forecasts
6.42 Africa Opioid Use Disorder Industry Drivers and Opportunities
7. OPIOID USE DISORDER MARKET OUTLOOK ACROSS SCENARIOS
7.1 Low Growth Case
7.2 Reference Growth Case
7.3 High Growth Case
8. OPIOID USE DISORDER COMPANY PROFILES
8.1 Profiles of Leading Opioid Use Disorder Companies in the Market
8.2 Business Descriptions, SWOT Analysis, and Growth Strategies
8.3 Financial Performance and Key Metrics
Alkermes
Camurus AB
Collegium Pharmaceutical
Hikma Pharmaceuticals PLC
Indivior PLC
MediciNova Inc
Omeros Corp
Orexo AB
Teva Pharmaceutical Industries Ltd
Titan Pharmaceuticals Inc
9. APPENDIX
9.1 Scope of the Report
9.2 Research Methodology and Data Sources
9.3 Glossary of Terms
9.4 Market Definitions
9.5 Contact Information
1.1 Opioid Use Disorder Market Overview and Key Findings, 2024
1.2 Opioid Use Disorder Market Size and Growth Outlook, 2021- 2030
1.3 Opioid Use Disorder Market Growth Opportunities to 2030
1.4 Key Opioid Use Disorder Market Trends and Challenges
1.4.1 Opioid Use Disorder Market Drivers and Trends
1.4.2 Opioid Use Disorder Market Challenges
1.5 Competitive Landscape and Key Players
1.6 Competitive Analysis- Growth Strategies Adopted by Leading Opioid Use Disorder Companies
2. OPIOID USE DISORDER MARKET SIZE OUTLOOK TO 2030
2.1 Opioid Use Disorder Market Size Outlook, USD Million, 2021- 2030
2.2 Opioid Use Disorder Incremental Market Growth Outlook, %, 2021- 2030
2.3 Segment Snapshot, 2024
3. OPIOID USE DISORDER MARKET- STRATEGIC ANALYSIS REVIEW
3.1 Porter's Five Forces Analysis
* Threat of New Entrants
* Threat of Substitutes
* Intensity of Competitive Rivalry
* Bargaining Power of Buyers
* Bargaining Power of Suppliers
3.2 Value Chain Analysis
3.3 SWOT Analysis
4. OPIOID USE DISORDER MARKET SEGMENTATION ANALYSIS AND OUTLOOK
4.1 Market Segmentation and Scope
4.2 Market Breakdown by Type, Application, and Other Segments, 2021-2030
By Drug
Buprenorphine
-Bunavail
-Sublocade
-Suboxone
-Zubsolv
-Others
Methadone
Naltrexone
By Route of Administration
Oral
Parenteral
By Distribution Channel
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies & Stores
4.3 Growth Prospects and Niche Opportunities, 2023- 2030
4.4 Regional comparison of Market Growth, CAGR, 2023-2030
5. REGION-WISE MARKET OUTLOOK TO 2030
5.1 Key Findings for Asia Pacific Opioid Use Disorder Market, 2025
5.2 Asia Pacific Opioid Use Disorder Market Size Outlook by Type, 2021- 2030
5.3 Asia Pacific Opioid Use Disorder Market Size Outlook by Application, 2021- 2030
5.4 Key Findings for Europe Opioid Use Disorder Market, 2025
5.5 Europe Opioid Use Disorder Market Size Outlook by Type, 2021- 2030
5.6 Europe Opioid Use Disorder Market Size Outlook by Application, 2021- 2030
5.7 Key Findings for North America Opioid Use Disorder Market, 2025
5.8 North America Opioid Use Disorder Market Size Outlook by Type, 2021- 2030
5.9 North America Opioid Use Disorder Market Size Outlook by Application, 2021- 2030
5.10 Key Findings for South America Opioid Use Disorder Market, 2025
5.11 South America Pacific Opioid Use Disorder Market Size Outlook by Type, 2021- 2030
5.12 South America Opioid Use Disorder Market Size Outlook by Application, 2021- 2030
5.13 Key Findings for Middle East and Africa Opioid Use Disorder Market, 2025
5.14 Middle East Africa Opioid Use Disorder Market Size Outlook by Type, 2021- 2030
5.15 Middle East Africa Opioid Use Disorder Market Size Outlook by Application, 2021- 2030
6. COUNTRY-WISE MARKET SIZE OUTLOOK TO 2030
6.1 US Opioid Use Disorder Market Size Outlook and Revenue Growth Forecasts
6.2 US Opioid Use Disorder Industry Drivers and Opportunities
6.3 Canada Market Size Outlook and Revenue Growth Forecasts
6.4 Canada Opioid Use Disorder Industry Drivers and Opportunities
6.6 Mexico Market Size Outlook and Revenue Growth Forecasts
6.6 Mexico Opioid Use Disorder Industry Drivers and Opportunities
6.7 Germany Market Size Outlook and Revenue Growth Forecasts
6.8 Germany Opioid Use Disorder Industry Drivers and Opportunities
6.9 France Market Size Outlook and Revenue Growth Forecasts
6.10 France Opioid Use Disorder Industry Drivers and Opportunities
6.11 UK Market Size Outlook and Revenue Growth Forecasts
6.12 UK Opioid Use Disorder Industry Drivers and Opportunities
6.13 Spain Market Size Outlook and Revenue Growth Forecasts
6.14 Spain Opioid Use Disorder Industry Drivers and Opportunities
6.16 Italy Market Size Outlook and Revenue Growth Forecasts
6.16 Italy Opioid Use Disorder Industry Drivers and Opportunities
6.17 Rest of Europe Market Size Outlook and Revenue Growth Forecasts
6.18 Rest of Europe Opioid Use Disorder Industry Drivers and Opportunities
6.19 China Market Size Outlook and Revenue Growth Forecasts
6.20 China Opioid Use Disorder Industry Drivers and Opportunities
6.21 India Market Size Outlook and Revenue Growth Forecasts
6.22 India Opioid Use Disorder Industry Drivers and Opportunities
6.23 Japan Market Size Outlook and Revenue Growth Forecasts
6.24 Japan Opioid Use Disorder Industry Drivers and Opportunities
6.26 South Korea Market Size Outlook and Revenue Growth Forecasts
6.26 South Korea Opioid Use Disorder Industry Drivers and Opportunities
6.27 Australia Market Size Outlook and Revenue Growth Forecasts
6.28 Australia Opioid Use Disorder Industry Drivers and Opportunities
6.29 South East Asia Market Size Outlook and Revenue Growth Forecasts
6.30 South East Asia Opioid Use Disorder Industry Drivers and Opportunities
6.31 Rest of Asia Pacific Market Size Outlook and Revenue Growth Forecasts
6.32 Rest of Asia Pacific Opioid Use Disorder Industry Drivers and Opportunities
6.33 Brazil Market Size Outlook and Revenue Growth Forecasts
6.34 Brazil Opioid Use Disorder Industry Drivers and Opportunities
6.36 Argentina Market Size Outlook and Revenue Growth Forecasts
6.36 Argentina Opioid Use Disorder Industry Drivers and Opportunities
6.37 Rest of South America Market Size Outlook and Revenue Growth Forecasts
6.38 Rest of South America Opioid Use Disorder Industry Drivers and Opportunities
6.39 Middle East Market Size Outlook and Revenue Growth Forecasts
6.40 Middle East Opioid Use Disorder Industry Drivers and Opportunities
6.41 Africa Market Size Outlook and Revenue Growth Forecasts
6.42 Africa Opioid Use Disorder Industry Drivers and Opportunities
7. OPIOID USE DISORDER MARKET OUTLOOK ACROSS SCENARIOS
7.1 Low Growth Case
7.2 Reference Growth Case
7.3 High Growth Case
8. OPIOID USE DISORDER COMPANY PROFILES
8.1 Profiles of Leading Opioid Use Disorder Companies in the Market
8.2 Business Descriptions, SWOT Analysis, and Growth Strategies
8.3 Financial Performance and Key Metrics
Alkermes
Camurus AB
Collegium Pharmaceutical
Hikma Pharmaceuticals PLC
Indivior PLC
MediciNova Inc
Omeros Corp
Orexo AB
Teva Pharmaceutical Industries Ltd
Titan Pharmaceuticals Inc
9. APPENDIX
9.1 Scope of the Report
9.2 Research Methodology and Data Sources
9.3 Glossary of Terms
9.4 Market Definitions
9.5 Contact Information
